...
首页> 外文期刊>Neurosurgical focus >Intracerebral hemorrhage secondary to intravenous and endovascular intraarterial revascularization therapies in acute ischemic stroke: An update on risk factors, predictors, and management
【24h】

Intracerebral hemorrhage secondary to intravenous and endovascular intraarterial revascularization therapies in acute ischemic stroke: An update on risk factors, predictors, and management

机译:急性缺血性卒中继发于静脉内和血管内动脉内血运重建治疗的脑出血:危险因素,预测因素和治疗方法的最新进展

获取原文
获取原文并翻译 | 示例
           

摘要

Intracerebral hemorrhage (ICH) secondary to intravenous and intraarterial revascularization strategies for emergent treatment of acute ischemic stroke is associated with high mortality. ICH from systemic thrombolysis typically occurs within the first 24-36 hours of treatment initiation and is characterized by rapid hematoma development and growth. Pathophysiological mechanisms of revascularization therapy-induced ICH are complex and involve a combination of several distinct processes, including the direct effect of thrombolytic agents, disruption of the bloodbrain barrier secondary to ischemia, and direct vessel damage from wire and microcatheter manipulations during endovascular procedures. Several definitions of ICH secondary to thrombolysis currently exist, depending on clinica lor radiological characteristics used. Multiple studies have investigated clinical and laboratory risk factors associated with higher rates of ICH in this setting. Early ischemic changes seen on noncontrast CT scanning are strongly associated with higher rates of hemorrhage. Modern imaging techniques, particularly CT perfusion, provide rapid assessment of hemodynamic parameters of the brain. Specific patterns of CT perfusion maps can help identify patients who are likely to benefit from revascularization or to develop hemorrhagic complications. There are no established guidelines that describe management of revascularization therapy-induced ICH, and great variability in treatment protocols currently exist. General principles that apply to the management of spontaneous ICH might not be as effecti ve for revascularization therapy-induced ICH. In this article, the authors review current knowledge of risk factors and radiological predictors of ICH secondary to stroke revascularization techniques and analyze medical and surgical management strategies for ICH in this setting.
机译:急性缺血性中风的急诊治疗继发于静脉内和动脉内血运重建策略的脑出血(ICH)与高死亡率相关。全身性溶栓引起的ICH通常在治疗开始的最初24-36小时内发生,其特点是血肿迅速发展和生长。由血运重建治疗引起的ICH的病理生理机制很复杂,涉及几个不同过程的组合,包括溶栓剂的直接作用,继发于缺血的血脑屏障的破坏以及血管内手术中导线和微导管操作对血管的直接损害。根据所使用的临床或放射学特征,目前存在溶栓继发性ICH的几种定义。在这种情况下,多项研究调查了与ICH发生率较高相关的临床和实验室风险因素。非对比CT扫描所见的早期缺血性改变与较高的出血率密切相关。现代成像技术,特别是CT灌注,可以快速评估大脑的血液动力学参数。 CT灌注图的特定模式可帮助识别可能受益于血运重建或发生出血并发症的患者。目前尚无描述血运重建治疗引起的ICH管理的既定指南,目前治疗方案存在很大差异。适用于自发性ICH治疗的一般原则可能对血运重建治疗引起的ICH无效。在本文中,作者回顾了脑卒中血运重建技术继发的ICH的危险因素和放射学预测因素的当前知识,并分析了在这种情况下ICH的药物和外科治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号